SOM — SomnoMed Cashflow Statement
0.000.00%
Last trade - 00:00- AU$51.51m
- AU$39.78m
- AU$114.62m
Annual cashflow statement for SomnoMed, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.011 | 0.007 | 0.03 | 0.023 | 0.087 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1.86 | -3.88 | -6.33 | 7.78 | 8.28 |
| Capital Expenditures | -8.79 | -6.41 | -5.34 | -3.98 | -5.74 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.317 | 0 | — | — | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | -8.47 | -6.41 | -5.34 | -3.98 | -5.74 |
| Financing Cash Flow Items | — | 0 | -2.07 | -0.044 | 1.97 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.09 | 6.61 | 16.7 | -3.38 | -1.47 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -5.47 | -3.69 | 4.22 | 1.11 | -0.109 |